Annovis Bio Inc - Efficacy in Cgic Endpoint Was Not Reached Due to Limited Number of Patients and Short Trial Duration
Annovis Bio Inc-由於患者數量有限和試驗時間短,未達到Cgic終點的療效
Annovis Bio Inc - Efficacy in Cgic Endpoint Was Not Reached Due to Limited Number of Patients and Short Trial Duration
Annovis Bio Inc-由於患者數量有限和試驗時間短,未達到Cgic終點的療效
使用瀏覽器的分享功能,分享給你的好友吧